Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

1715 Results

Guidelines and Advice

The Use of Targeted Therapies in Patients with Inoperable Locally Advanced or Metastatic Renal Cell Cancer: Updated Guideline 2017

Status: In-Review
ID: 3-8-4
Version: 2

May 2017

Guidelines and Advice

An Endorsement of the ASTRO/ESTRO 2023 Guideline for the Treatment of Patients with Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer

Status: Current
ID: GL END 7-24

Nov 2024

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Aug 2022

Guidelines and Advice

Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline

Status: In-Review
ID: 3-15
Version: 2

Sep 2014

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Status: Current
ID: 7-A-2018-2
Version: N/A

Jan 2020

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Mar 2025

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Guidelines and Advice

Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: American Society of Clinical Oncology (ASCO) and Ontario Health (Cancer Care Ontario) Joint Guideline Update

Status: Current
ID: 7-A-2018-3

Feb 2021

Guidelines and Advice

Fecal Immunochemical Tests Compared With Guaiac Fecal Occult Blood Tests for Population-Based Colorectal Cancer Screening

Status: Archived
ID: 15-8

Nov 2011

Guidelines and Advice

Diagnostic Imaging in Breast Cancer

Status: Archived
ID: DIBrCa

Apr 2012

Guidelines and Advice

Cross-Sectional Imaging in Colorectal Cancer

Status: Archived
ID: DICRC

Sep 2012

Pages